(Total Views: 481)
Posted On: 12/21/2022 8:00:49 AM
Post# of 102

$CTSO News Article - CytoSorbents Receives Recommendation from Independent Data and Safety Monitoring Board to Continue Pivotal STAR-T Trial As Planned Without Modifications https://marketwirenews.com/news-releases/cyto...36000.html


My Twitter: WhyteStocks